15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN, NJ
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Other Events
Announces Reverse Stock Split
Tevogen Bio Holdings Inc. Approves Plan Amendment and Reverse Stock Split
Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
News, Underwriting Agreement, Legal Opinion
Q1
FY 2025
Q3
Q2
FY 2024
Notice of Late Filing for Annual Report
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement